Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts

Ge,Shenglei; Mao,Yitao; Yi,Yan; Xie,Dinghua; Chen,Zhuchu; Xiao,Zhiqiang

doi:10.3892/etm.2012.483

Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts

Authors:
- Shenglei Ge
- Yitao Mao
- Yan Yi
- Dinghua Xie
- Zhuchu Chen
- Zhiqiang Xiao
View Affiliations

Affiliations: Department of Otolaryngology - Head and Neck Surgery, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, P.R. China, Department of Hematology, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, P.R. China, Institute of Oncology, Xiang-ya Medical College, Central South University, Changsha, Hunan, P.R. China
Published online on: February 13, 2012 https://doi.org/10.3892/etm.2012.483
Pages: 857-860

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Since the concept of the secretome (ensemble of proteins secreted and/or shed from cells) was proposed, it has become an attractive and challenging proteomic technology in recent years. However, secretome analysis still faces some difficulties mainly related to sample collection and preparation. In the present study, we established a reliable method for extracting secreted proteins by ultrafiltration centrifugation and conducting secretomic analysis. Accumulating evidence suggests that carcinoma-associated stromal fibroblasts (CAFs) play an important role in cancer initiation and progression. To investigate the expression patterns of secreted proteins from fibroblasts and to identify the secreted proteins involved in nasopharyngeal carcinoma (NPC) carcinogenesis, we conducted comparative secretome analysis between CAFs and normal fibroblasts. After two-dimensional gel electrophoresis (2-D PAGE), 11 significant spots were differentially expressed and identified by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). These proteins may take part in the regulation of the tumor microenvironment through different processes. The expression level of galectin-1 in the CAF supernatant was also determined by ELISA. This study provides useful information and new clues for the further understanding of the regulatory mechanisms of CAFs in the NPC microenvironment.

View Figures

View References

1.	Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
2.	Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD and Rowley DR: Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 65:8887–8895. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Maeda T, Desouky J and Friedl A: Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene. 25:1408–1412. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
5.	Yamada KM and Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell. 130:601–610. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Debnath J and Brugge JS: Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 5:675–688. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Hu M, Yao J, Cai L, Bachman KE, van den Brûle F, Velculescu V and Polyak K: Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 37:899–905. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Tjalsma H, Bolhuis A, Jongbloed JD, Bron S and van Dijl JM: Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev. 64:515–547. 2000. View Article : Google Scholar : PubMed/NCBI
9.	Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Mürdter TE and Aulitzky WE: Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC Cancer. 8:3642008. View Article : Google Scholar : PubMed/NCBI
10.	Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang PF, Li C, Peng F, Tang CE, Li JL, Chen ZC and Xiao ZQ: Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 70:3450–3562. 2010. View Article : Google Scholar : PubMed/NCBI
11.	May M: From cells, secrets of the secretome leak out. Nat Med. 15:8282009. View Article : Google Scholar : PubMed/NCBI
12.	Pavlou MP and Diamandis EP: The cancer cell secretome: a good source for discovering biomarkers? J Proteomics. 73:1896–1906. 2010.PubMed/NCBI
13.	Boraldi F, Bini L, Liberatori S, Armini A, Pallini V, Tiozzo R, Ronchetti IP and Quaglino D: Normal human dermal fibroblasts: proteomic analysis of cell layer and culture medium. Electrophoresis. 24:1292–1310. 2003. View Article : Google Scholar : PubMed/NCBI
14.	Cao J, Hu Y, Shen C, Yao J, Wei L, Yang F, Nie A, Wang H, Shen H, Liu Y, Zhang Y, Tang Y and Yang P: Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells. Proteomics. 9:4881–4888. 2009. View Article : Google Scholar : PubMed/NCBI
15.	Archakov AI, Ivanov YD, Lisitsa AV and Zgoda VG: AFM fishing nanotechnology is the way to reverse the Avogadro number in proteomics. Proteomics. 7:4–9. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Huang CM, Wang CC, Barnes S and Elmets CA: In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics. 6:5805–5814. 2006. View Article : Google Scholar : PubMed/NCBI
17.	Xu X, Yuan G, Liu W, Zhang Y and Chen W: Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance. Exp Oncol. 31:102–105. 2009.PubMed/NCBI
18.	Tang CE, Guan YJ, Yi B, Li XH, Liang K, Zou HY, Yi H, Li MY, Zhang PF, Li C, Peng F, Chen ZC, Yao KT and Xiao ZQ: Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J Proteome Res. 9:6101–6111. 2010.
19.	Yi B, Tan SX, Tang CE, Huang WG, Cheng AL, Li C, Zhang PF, Li MY, Li JL, Yi H, Peng F, Chen ZC and Xiao ZQ: Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem. 106:858–866. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Tang CE, Tan T, Li C, Chen ZC, Ruan L, Wang HH, Su T, Zhang PF and Xiao ZQ: Identification of galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol Rep. 24:495–500. 2010.PubMed/NCBI